Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Low Disease Activity Over 4 Years of Ocrelizumab Therapy in Treatment-Naive Patients With Early-Stage Relapsing-Remitting Multiple Sclerosis; the Phase IIIb ENSEMBLE Study

Author:Bermel, Robert   Hartung, Hans-Peter   Brochet, Bruno   Benedict, Ralph   Berger, Thomas   Carroll, William   Vollmer, Timothy   Holmoy, Trygve   Karabudak, Rana   Killestein, Joep   Nos, Carlos   Patti, Francesco   Perrin Ross, Amy   Vanopdenbosch, Ludo   Wuerfel, Jens   Kuenzel, Thomas   Kadner, Karen   Kulyk, Inessa   Freedman, Mark   

Session Name:S46: MS Therapeutics and Clinical Decision Making  

Topic:MS and Inflammatory Disease  

Program Number:S46.004  

Author Institution:Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH  Deptartment of Neurology, Heinrich-Heine-University Düsseldorf, Germany, Dusseldorf, Germany  Université de Bordeaux, Neurocentre Magendie INSERM, Bordeaux, France, Bordeaux, France  Jacobs School of Medicine and Biomedical Sciences, Department of Neurology, University of Buffalo, NY, USA, Buffalo, NY  Dept. of Neurology, Medical University of Vienna, Vienna, Austria  Department of Neurology, Sir Charles Gairdner Hospital, Perron Institute for Neurological and Translational Science, The University of Western Australia, Nedlands, Australia, Subiaco, Australia  Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA, Aurora, CO  Department of Neurology, Akershus University Hospital, Lørenskog, Norway, Lasker, Norway  Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey, Ankara, Turkey  Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands, Amsterdam, Netherlands  Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d’Hebron Hospital Universitari, Barcelona, Spain, Barcelona, Spain  Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Neuroscience Section and Multiple Sclerosis Centre, University of Catania PO Policlinico G Rodolico, Catania, Italy, Catania, Italy  Loyola University Chicago, Chicago, IL, USA, Oak Brook, IL  Department of Neurology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium, Brugge, Belgium  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute Ottawa, ON, Canada., Ottawa, ON, Canada  

Genotype-Phenotype correlation in Parkin-Parkinson’s disease

Author:Jayadev Menon, Poornima   Sambin, Sara   Criniere-Boizet, Baptiste   Courtin, Thomas   Casse, Fanny   Tesson, Christelle   Ferrien, Melanie   Flamand-Roze, Emmanuel   Lejeune, Francois-Xavier   Lanore, Aymeric   Mangone, Graziella   Mariani, Louise-Laure   Aasly, Jan   Gan Or, Ziv   Yu, Eric   Dauvilliers, Yves   Zimprich, Alexander   Alvarez Fernandez, Ignacio   Pastor, Pau   Di Fonzo, Alessio   Bhatia, Khailash   Magrinelli, Francesca   Houlden, Henry   Real, Raquel   Narendra, Derek   Lin, Hsin-Pin   Jovanovic, Carna   Koks, Sulev   Lynch, Timothy   Gallagher, Amy   Vandenberghe, Wim   Gasser, Thomas   Morris, Huw   Klein, Christine   Brockmann, Kathrin   Corti, Olga   Brice, Alexis   Lesage, Suzanne   Corvol, Jean-Christophe   

Session Name:P3: Movement Disorders: Biomarkers and Genetics of Parkinson's Disease 1  

Topic:Movement Disorders  

Program Number:P3.012  

Author Institution:ICM/ Paris Brain Institute, Paris, France  NTNU, Trondheim, Norway  Mcgill University, Montreal, QC, Canada  Montpellier, Montpellier, France  Medizinische Universität Wien, Vienna, Austria  University Mutua de Terrassa, Terrassa, Spain  University of Milan, Milan, Italy  UCL, London, United Kingdom  NIH, Bethesda, MD  University of Belgrade, Belgrade, Serbia  University of Perron, Perth, Australia  Dublin Neurological Institute, Dublin, Ireland  University of Leuven, Leuven, Belgium  University of Tuebingen, Tuebingen, Germany  University of Luebeck, Luebeck, Germany